DANIELLE FABIAN: Open Payments
NPI 1134870710 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 10 payments from 4 companies in 2025. Trend: 2023 $345 · 2024 $246 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $161 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Greer Laboratories, Inc. | 1 | $14 |
Products named: FASENRA, Rhapsido, ORALAIR, DUPIXENT.
Industry payments across ME — which companies pay providers there.
